EIM
IMDZ

Essex Investment Management’s Immune Design Corp. IMDZ Stock Holding History

Essex Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-42,179
Closed -$192K – 460
2018
Q2 		$192K Buy
+42,179
New +$168K 0.02% 381

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's IMDZ Position: Q3 2018 in Review

Essex Investment Management sold out of Immune Design Corp. (IMDZ) in Q3 2018, closing a stake of 42,179 shares — an estimated $192K sold.

Essex Investment Management first reported a position in IMDZ in Q2 2018 and held it in 1 quarter. The position peaked at $192K in Q2 2018. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • Essex Investment Management reported no remaining Immune Design Corp. position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 42,179 Immune Design Corp. shares in Q3 2018, an estimated $192K.
  • Essex Investment Management first reported a position in Immune Design Corp. in Q2 2018 and held it in 1 quarter.
  • Essex Investment Management's Immune Design Corp. position peaked at $192K in Q2 2018.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.